CRE25-050: Durable Response to Immunotherapy Rechallenge With Double Immunotherapy for a Patient With Advanced Non-Small Cell Lung Cancer

By sjmartinez • March 30, 2025

Huynh JT, Li R, Shin DS. CRE25-050: Durable Response to Immunotherapy Rechallenge With Double Immunotherapy for a Patient With Advanced Non-Small Cell Lung Cancer. J Natl Compr Canc Netw. 2025 Mar 28;23(3.5):CRE25-050. doi: 10.6004/jnccn.2024.7225. PMID: 40154310.

Tags: Fellow, General Internal Medicine, Hematology/Oncology, Publications, Resident

The State of VA-funded Women Veterans’ Health Systems Research

Borsky AE, Kroll-Desrosiers A, Rodriguez A, Fenwick K, Friedman JK, Yano EM. The State of VA-funded Women Veterans' Health Systems Research. Womens Health Issues. 2025[...]

Clinical Telavancin Failure in Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia

Dao KT, D'Assumpcao C, Sharma R, Singh C, Kuran R, Heidari A. Clinical Telavancin Failure in Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia. Cureus. 2025 Feb 24;17(2):e79588.[...]

Behavioral and Nutritional Needs of Transgender and Gender Diverse Patients

Delgado D, Kang EH, Williams K, Weimer AK. Behavioral and Nutritional Needs of Transgender and Gender Diverse Patients. Transgend Health. 2025 Feb 10;10(1):104-108. doi: 10.1089/trgh.2023.0108.[...]